Article
Expression of the multiple drug resistance gene (mdr-1) and epitope masking in chronic lymphatic leukaemia.
British journal of haematology - 1 Oct 1990
Cumber P M, Jacobs A, Hoy T, Fisher J, Whittaker J A, Tsuruo T, Padua R A
Abstract excerpt
Resistance to cytotoxic agents is a common clinical problem in the treatment of chronic lymphatic leukaemia (CLL). The multidrug resistant (MDR) phenotype characterized by increased levels of a specific cell membrane p-glycoprotein, confers cross resistance to a wide range of structurally dissimilar antineoplastic drugs. We have studied the expression of this p-glycoprotein in chronic lymphatic leukaemia measured...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
